Just Published: "XDx, Inc. - Product Pipeline Analysis, 2014 Update"
XDx, Inc. (XDx) is a molecular diagnostics company. The company discovers, develops, and commercializes clinically differentiated and non-invasive tests to monitor immune status in transplant recipients and autoimmune disease and potentially improve long-term patient outcomes. It commercializes AlloMap molecular expression testing, which aids clinicians in identifying heart transplant recipients with stable graft function. XDx applies genomics and bioinformatics technology to develop molecular diagnostic assays based on gene expression patterns in blood cells that provide clinically useful information. It partners and...
View full press release